Bausch Site 109

Nashville, Tennessee 37205

0 studies enrolling now · 2 studies all time

What they study most

Dry Eye Disease (DED)

Studies at this site

• Perfluorohexylcotane (NOV03) for the Treatment of Signs and Symptoms of Dry Eye Disease Associated With Meibomian Gland Dysfunction (Gobi Study) — Completed
• Long-Term Safety and Tolerability of NOV03 (Perfluorohexyloctane) in Subjects Who Completed Trial NVU-003 (Kalahari Study) — Completed